Thus, inhibition of de novo F-actin polymerization and the AR in CLL cells was sufficient to turn the initially highly resistant MEC-1 cell line into a highly susceptible phenotype. The gene discussed is AR; the disease is B-cell chronic lymphocytic leukemia.